Use of vaccines as a key antimicrobial stewardship strategy

South African Medical Journal

Volumn 105, Issue 5, 2015, Pages 431-433

  Brink, A J ^a   Richards, G A ^b  

^a MILPARK HOSPITAL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL VACCINE; CEFTRIAXONE; HAEMOPHILUS INFLUENZAE VACCINE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; VIRUS VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; DISEASE ASSOCIATION; DRUG EFFICACY; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; IMMUNIZATION; INFLUENZA VACCINATION; MICROBIAL COLONIZATION; PNEUMOCOCCAL INFECTION; PREVENTIVE HEALTH SERVICE; SOUTH AFRICA; STREPTOCOCCUS PNEUMONIAE;

EID: 84929998347     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.9651     Document Type: Article

References (17)

1. Azzari C, Martinon-Torres F, Schmitt H-J, Dagan R. Evolving role of 13-valent pneumococcal conjugate vaccine in clinical practice. Pediatr Infect Dis J 2014;33:858-864. [http://dx.doi.org/10.1097/INF.0000000000000328].
2. Harboe ZB, Dalby T, Weinberger DM, et al. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis 2014;59:1066-1073. [http://dx.doi.org/10.1093/cid/ciu524].
3. Von Gottberg A, de Gouveia L, Tempia S, et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med 2014;371:1889-1899. [http://dx.doi.org/10.1056/NEJMoa1401914].
4. Cohen C, von Mollendorf C, de Gouveia L, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine (PCV-7) against invasive pneumococcal disease in HIV-infected and-uninfected children in South Africa: A matched case-control study. Clin Infect Dis 2014;59:808. [http://dx.doi.org/10.1093/cid/ciu431].
5. Becker-Dreps S, Amaya E, Liu L, et al. Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumocovaccine in Nicaragua. Pediatr Infect Dis J 2014;33:637-642. [http://dx.doi. org/10.1097/INF.0000000000000269].
6. Ben-Shimol S, Givon-Lavi N, Leibovitz E, Dagan R. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis 2014;59:1724-1732. [http://dx.doi. org/10.1093/cid/ciu683].
7. Olarte L, Hulten KG, Lamberth L, et al. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis Streptococcus pneumoniae in children. Pediatr Infect Dis J 2014;33:1033-1036. [http://dx.doi.org/10.1097/INF.0000000000000387].
8. Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: A randomised double-blind efficacy study. Lancet 2006;367:740-748. [http://dx.doi.org/10.1016/s0140-6736(06)68304-9].
9. Fireman B, Black SB, Shinefield HR, et al. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 2003;22:10-16. [http://dx.doi.org/10.1097/00006454-200301000-00006].
10. Dagan R, Sikuler-Cohen M, Zamir O, et al. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J 2001;20:951-958. [http://dx.doi.org/10.1097/00006454-200110000-00008].
11. Zhou F, Shefer A, Kong Y, et al. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics 2008;121:253-260. [http://dx.doi. org/10.1542/peds.2007-0619].
12. Palmu AA, Jokinen J, Nieminen H, et al. Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: A double-blind, cluster randomised phase 3-4 trial. Lancet Infect Dis 2014;14: 205-212. [http://dx.doi.org/10.1016/s1473-3099(13)70338-4].
13. Cohen R, Levy C, de La Rocque F, et al. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J 2006;25:1001-1007. [http://dx.doi.org/10.1097/01.inf.0000243163.85163.a8].
14. Hicks LA, Chien Y, Taylor TH, et al. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumonia in the United States, 1996-2003. Clin Infect Dis 2011;53:631-639. [http://dx.doi.org/10.1093/cid/cir443].
15. Kwong JC, Maaten S, Upshur REG, et al. The effect of universal influenza immunization on antibiotic prescriptions: An ecological study. Clin Infect Dis 2009;49:750-756. [http://dx.doi.org/10.1086/605087].
16. Maltezou HC, Fotiou A, Antonakopoulos N, et al. Impact of postpartum influenza vaccination of mothers and household contacts in preventing febrile episodes, influenza-like illness, healthcare seeking, and administration of antibiotics in young infants during the 2012-2013 influenza season. Clin Infect Dis 2013;57:1520-1526. [http://dx.doi.org/10.1093/cid/cit599].
17. Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014;371:918-931. [http://dx.doi.org/10.1056/NEJMoa1401480].